Holen Sie sich die Stockscreener-App
34.15
1.78%
0.46
Schlusskurs vom Vortag:
$33.69
Offen:
$34
24-Stunden-Volumen:
146.84K
Relative Volume:
0.14
Marktkapitalisierung:
$5.38B
Einnahmen:
$5.29B
Nettoeinkommen (Verlust:
$191.46M
KGV:
28.98
EPS:
1.1785
Netto-Cashflow:
$298.82M
1W Leistung:
+0.03%
1M Leistung:
-9.31%
6M Leistung:
+251.70%
1J Leistung:
+192.09%
1-Tages-Spanne:
$33.64
$34.78
1-Wochen-Bereich:
$33.26
$34.95
52-Wochen-Spanne:
$7.50
$43.08
Pacs Group Inc Stock (PACS) Company Profile
Firmenname
Pacs Group Inc
Sektor
Branche
Telefon
(801) 447-9829
Adresse
90 S. 400 W. SUITE 700, SALT LAKE CITY
Compare PACS vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
34.23 | 5.29B | 5.29B | 191.46M | 298.82M | 1.1785 |
|
HCA
Hca Healthcare Inc
|
535.49 | 119.10B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
223.50 | 19.54B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.80 | 12.71B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
209.69 | 12.11B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
193.03 | 11.64B | 17.36B | 1.51B | 849.25M | 23.15 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-06 | Fortgesetzt | JP Morgan | Overweight |
| 2024-10-09 | Eingeleitet | UBS | Buy |
| 2024-09-11 | Fortgesetzt | Citigroup | Buy |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-05-06 | Eingeleitet | Citigroup | Buy |
| 2024-05-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-05-06 | Eingeleitet | Stephens | Overweight |
| 2024-05-06 | Eingeleitet | Truist | Buy |
Alle ansehen
Pacs Group Inc Aktie (PACS) Neueste Nachrichten
Technical Reactions to PACS Trends in Macro Strategies - Stock Traders Daily
Does PACS Group’s (PACS) Optum CEO Board Addition Reframe Its Value-Based Care Ambitions? - Sahm
PACS Group Earnings Call Highlights Profitable, Disciplined Growth - The Globe and Mail
PACS Group, Inc. (PACS) Raised to Strong Buy: The Reasons Explained - Bitget
PACS Group, Inc. (PACS) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Is PACS Group (PACS) Pricing Reflect Its Recent Share Price Pullback And Growth Hopes - Yahoo Finance
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-03-08 | PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PACS | Press Release - Stockhouse
Pacs (PACS) Hits 52-Week High on Q3 Blowout - MSN
PACS Group (NYSE:PACS) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
PACS Group adds former CMS official Patrick Conway to board By Investing.com - Investing.com Canada
PACS Group, Inc. 8-K Filing: Company Information, Common Stock Trading Details, and SEC Compliance Disclosure (March 2026) - Minichart
PACS Group adds former CMS official Patrick Conway to board - Investing.com
PACS Group Appoints Patrick Conway to Board of Directors - TipRanks
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PACS vs. MEDP: Which Stock Is the Better Value Option? - Bitget
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors - 01net
Does PACS Group, Inc. (PACS) Have the Potential to Rally 25.45% as Wall Street Analysts Expect? - Finviz
PACS Group Appoints Dr. Patrick Conway to Board - National Today
Pacs Group, Inc. appoints Dr. Patrick Conway, MD, MSc to board of directors - marketscreener.com
Best Momentum Stock to Buy for March 5th - Yahoo Finance Australia
Best Value Stock to Buy for March 5th - Yahoo Finance
A Look At PACS Group (PACS) Valuation After Record 2025 Results And New 2026 Guidance - simplywall.st
5 Analysts Assess PACS Group: What You Need To Know - Benzinga
PACS Stock Receives Updated "Buy" Rating from UBS Today | PACS S - GuruFocus
PACS Group (NYSE:PACS) Price Target Raised to $44.00 at UBS Group - MarketBeat
UBS Adjusts PACS Group Price Target to $44 From $42, Maintains Buy Rating - marketscreener.com
PACS Group Inc (PACS) Shares Up 2.9% on Mar 4 - GuruFocus
Oppenheimer Adjusts Price Target on PACS Group to $42 From $40, Maintains Outperform Rating - marketscreener.com
PACS Group (NYSE:PACS) Price Target Raised to $42.00 at Oppenheimer - MarketBeat
PACS Group (PACS) awards 30,000 restricted stock units to Chief Compliance Officer - Stock Titan
PACS Group (NASDAQ: PACS) awards 25,000 RSUs to HR chief - Stock Titan
PACS (PACS) logs Form 3 insider status for Chief Compliance Officer - Stock Titan
PACS Group (PACS) HR chief Bingham Trent Dean files initial Form 3 - Stock Titan
PACS Group, Inc. (PACS) Stock Analysis: A Promising 20.63% Upside in the Healthcare Sector - DirectorsTalk Interviews
PACS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PACS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PACS Group Receives 'Moderate Buy' Rating from Analysts - National Today
RBC Capital raises PACS Group stock price target on strong guidance - Investing.com UK
RBC Raises Price Target on PACS Group to $52 From $47, Keeps Outperform Rating - marketscreener.com
PACS Group, Inc. $PACS Shares Purchased by Royce & Associates LP - MarketBeat
PACS Group, Inc. (NYSE:PACS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is PACS Group’s (PACS) Aggressive Acquisition Plan Strengthening Its Core Skilled Nursing Advantage? - Sahm
Long-term care’s new rock stars are changing the tune - McKnight's Long-Term Care News
PACS Group Stock Drops 12% Despite Record Profits: Event: Do Analysts See a Recovery in 2026? - TIKR.com
PACS Group (PACS) Margin Jump To 3.6% Tests Rich 29.9x P/E Narrative - simplywall.st
PACS Group Q4 Earnings Call Highlights - MarketBeat
PACS Group’s Expansion And ESOP Move Test Growth And Execution Story - Yahoo Finance
PACS Group ESOP Shelf Spurs Questions On Dilution And Staff Alignment - Sahm
Assessing PACS Group (PACS) Valuation After Strong Long Term Returns And Recent Share Price Pullback - Yahoo Finance
PACS Group Inc (PACS) Gets a Buy from RBC Capital - The Globe and Mail
Finanzdaten der Pacs Group Inc-Aktie (PACS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):